Q&A with Nobel Laureate Michael Rosbash

A basic curiosity about how life works led the Brandeis University molecular biologist to discover how our bodies keep time.

Written byAshley Yeager
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Michael Rosbash of Brandeis University shared the 2017 Nobel Prize in Physiology and Medicine for work on circadian rhythms.SCOTT EISEN/HOWARD HUGHES MEDICAL INSTITUTEToday (October 2), Michael Rosbash, Jeffrey Hall, and Michael Young were awarded the 2017 Nobel Prize in Physiology or Medicine for explaining how organisms synch their behavior and physiology to Earth’s 24-hour spin cycle. Brandeis University’s Rosbash spoke with The Scientist about what inspired the award-winning work and what the biggest challenges are now in understanding circadian rhythms.

The Scientist: How did you become interested in studying genes related to circadian rhythm?

Michael Rosbash: The origin of the interest is a basic understanding of questions like, why your mother has the quirks she does or why your two children come out differently. It is just a natural curiosity about the world around us. The question is, “What is this really all about? How does this work?” Scientists like reduction, so then the question becomes, how do you break down the problem so it is really manageable, so you could study it and learn something concrete?

I always had an interest in the biological underpinnings of behavior, but as a biochemist or molecular biologist, it always seemed difficult to study. My colleague Jeff Hall ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies